Seeking Alpha

Alexza Pharmaceuticals (ALXA +41%) is soaring today on no specific news. One possible lead could...

Alexza Pharmaceuticals (ALXA +41%) is soaring today on no specific news. One possible lead could come from the company's earnings call transcript, released late Friday. It provided further color on recent inspections by both the EMA and FDA on its Mountain View facility, and an update on the anticipated approval of its schizophrenia and bipolar disorder drug Adsuasive, which is expected to get clearance in both Europe and the U.S. later this year. (Transcript)
Comments (0)
Be the first to comment
DJIA (DIA) S&P 500 (SPY)
ETF Tools
Find the right ETFs for your portfolio:
Seeking Alpha's new ETF Hub
ETF Investment Guide:
Table of Contents | One Page Summary
Read about different ETF Asset Classes:
ETF Selector